The shares of this leading insurance company are in focus after a 2.72 percent equity stake exchange via a block deal. In this article, we will discuss more about this in detail.
With a market capitalisation of Rs 24,941 crores, the shares of Star Health & Allied Insurance Company Ltd are currently trading at Rs 424 per share, down by 32.54 percent from its 52-week high of Rs 647.65 per share. In the last one year, the stock has delivered a negative return of 19 percent.
On Wednesday, India’s largest fund house in terms of assets, has bought 1.6 crore shares, or a 2.72 percent equity stake, in the company via a block trade. Based on the number of shares, the transaction size is estimated at around Rs 672 crore, executed at an average price of Rs 420 per share. As of March 2025, promoters hold 57.67 percent of the company, followed by FIIs with 18.69 percent, DIIs with 15.44 percent, and the public with 8.22 percent.
Financial Highlights
The company reported a revenue of Rs 16,101 crores in FY25, up by 15 percent from its FY24 revenue of Rs 14,022 crores. However, the company reported a net profit decline of 23.55 percent to Rs 646 crore in FY25 from Rs 845 crores in FY24.
The stock delivered an ROE and ROCE of 9.57 percent and 12 percent, respectively, and is currently trading at a P/E of 38.64x as compared to its industry average of 39.47x.
Star Health and Allied Insurance Company Limited is among the biggest health insurance companies in India and offers a comprehensive course suite of individual, family, senior citizen health insurance and group mediation health insurance.
Examples of specially curated coverage plans available are dedicated and specific coverage plans for autism, cardiac and cancer, women related plans with a surrogacy or oocyte donatory benefit, travel insurance, and personal accident insurance. The distribution of their products is multifaceted through web aggregators, digital platforms, agents, brokers, and corporate partners..
Written by Satyajeet Mukherjee
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
The post Block Deal: Smallcap stock in focus after SBI acquired 2.72% stake worth ₹672 Cr in the company appeared first on Trade Brains.